ANAC - Anacor Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
-99.20 (0.00%)
At close: 7:00PM EST
Stock chart is not supported by your current browser
Previous Close99.20
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist8 months ago

    Dupixent Could Substantially Drive Regeneron’s Growth

    In March 2017, the FDA approved Regeneron and Sanofi’s Dupixent injection for the treatment of adult individuals with moderate to severe atopic dermatitis.

  • We're sorry this is all we were able to find about this topic.